In December, 2009, NAMSA announced the acquisition of Alquest, a medical device-focused clinical research organization based in Minneapolis. In order to communicate more effectively with clients, regulatory agencies and other stakeholders around the world, we are now operating under a single, unified brand. Therefore, Alquest is formally conducting business under the NAMSA name.
Of most significance to NAMSA’s clients is direct access to a broader array of services and global expertise to leverage across the entire product development process. Though clients are familiar with many of our services, we have taken this opportunity to restructure our services in five categories:
- Regulatory and Quality Systems Consulting,
- Research and Development Support,
- Non-Clinical Testing,
- Clinical Research, and
- Post Market Support.